| SC 13D | 2016-07-13 | Dexxon Holdings Ltd. | Arbutus Biopharma Corp | 16,013,540 | 29.3% | EDGAR |
| SC 13D/A | 2016-02-17 | Roivant Sciences Ltd. | Arbutus Biopharma Corp | 16,013,540 | 29.3% | EDGAR |
| SC 13D/A | 2016-02-17 | Dexxon Holdings Ltd. | Arbutus Biopharma Corp | 0 | 0.0% | EDGAR |
| SC 13D/A | 2016-02-17 | QVT Financial LP | Arbutus Biopharma Corp | 0 | 0.0% | EDGAR |
| SC 13G/A | 2016-02-16 | RA CAPITAL MANAGEMENT, LLC | Arbutus Biopharma Corp | 0 | 0.0% | EDGAR |
| SC 13G/A | 2016-02-16 | Falcon Edge Capital LP | Arbutus Biopharma Corp | 2,618,000 | 4.8% | EDGAR |
| SC 13G/A | 2016-02-12 | PRIMECAP MANAGEMENT CO/CA/ | Arbutus Biopharma Corp | 2,930,982 | 5.4% | EDGAR |
| SC 13G/A | 2016-02-10 | FRANKLIN RESOURCES INC | Arbutus Biopharma Corp | 1,287,560 | 2.4% | EDGAR |
| SC 13G | 2015-09-10 | PRIMECAP MANAGEMENT CO/CA/ | Arbutus Biopharma Corp | 2,813,000 | 5.2% | EDGAR |
| SC 13D/A | 2015-08-26 | Roivant Sciences Ltd. | Arbutus Biopharma Corp | 16,013,540 | 29.5% | EDGAR |
| SC 13D | 2015-03-16 | Dexxon Holdings Ltd. | TEKMIRA PHARMACEUTICALS Corp | 16,013,540 | 34.4% | EDGAR |
| SC 13D | 2015-03-16 | Roivant Sciences Ltd. | TEKMIRA PHARMACEUTICALS Corp | 16,013,540 | 34.4% | EDGAR |
| SC 13D | 2015-03-16 | QVT Financial LP | TEKMIRA PHARMACEUTICALS Corp | 16,013,540 | 34.4% | EDGAR |
| SC 13G/A | 2015-03-06 | NEWBY STEVEN T | TEKMIRA PHARMACEUTICALS Corp | - | - | EDGAR |
| SC 13G | 2015-02-10 | FRANKLIN RESOURCES INC | TEKMIRA PHARMACEUTICALS Corp | 1,635,850 | 7.3% | EDGAR |
| SC 13G | 2015-01-22 | Falcon Edge Capital LP | TEKMIRA PHARMACEUTICALS Corp | 2,221,000 | 9.9% | EDGAR |
| SC 13G | 2015-01-20 | RA CAPITAL MANAGEMENT, LLC | TEKMIRA PHARMACEUTICALS Corp | 2,214,800 | 9.9% | EDGAR |
| SC 13G/A | 2014-02-18 | NEWBY STEVEN T | TEKMIRA PHARMACEUTICALS Corp | - | - | EDGAR |
| SC 13G/A | 2014-02-13 | GrowthWorks Capital Ltd. | TEKMIRA PHARMACEUTICALS Corp | 0 | - | EDGAR |
| SC 13G | 2014-01-10 | FRANKLIN RESOURCES INC | TEKMIRA PHARMACEUTICALS Corp | 2,022,400 | 10.6% | EDGAR |